Formation Bio is a pioneering technology and AI-driven pharmaceutical company that was founded in 2016, originally known as TrialSpark Inc. The company is dedicated to transforming drug development by enhancing efficiency and addressing significant bottlenecks in clinical trials that impede the progress of new medicines. Formation Bio achieves this by developing advanced technology platforms and processes aimed at accelerating all facets of drug development. Collaborating closely with pharmaceutical companies, research organizations, and biotech firms, Formation Bio works to acquire and advance drugs beyond their clinical proof of concept, thereby facilitating the introduction of innovative treatments to patients. The company boasts a strong backing from notable investors in both the pharmaceutical and tech sectors, including a16z, Sequoia, and Sanofi, which underscores its commitment to revolutionizing the industry through AI and data-driven methodologies. Formation Bio's core values are fundamental to its mission of rapidly delivering new therapies to patients while fostering a collaborative environment among its teams.